Figure 6From: The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsMigration of PACs cultured from type 2 diabetic patients (A) and healthy controls (B) in the presence and in the absence of Saxagliptin and SDF-1α was assessed using a transwell system. *p < 0.05 versus the untreated control condition (Ctrl).Back to article page